ARCT FY 2024 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$217M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$138M-12.3% YoY

Gross Profit

$138M100.0% margin

Operating Income

-$96M-69.1% margin

Net Income

-$81M-58.5% margin

EPS (Diluted)

$-3.00

Cash Flow

Operating Cash Flow

-$60M

Free Cash Flow

-$60M

Stock-Based Comp.

$38M

Balance Sheet

Total Assets

$344M

Total Liabilities

$103M

Stockholders' Equity

$241M

Cash & Equivalents

$237M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$138M	$158M	-12.3%
Gross Profit	$138M	$158M	-12.3%
Operating Income	-$96M	-$78M	-22.3%
Net Income	-$81M	-$30M	-172.3%